Coumarin

Coumarin

SCHEMBL3632884

C1CCNCC1.O=c1ccc2ccccc2o1.c1ccc2c(c1)CCCO2

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 1/20 0.48
▸ CA1 P00915 1/20 0.48
▸ CA2 P00918 1/20 0.48
▸ LMNA P02545 1/20 0.48
▸ CA3 P07451 1/20 0.48
▸ CA4 P22748 1/20 0.48
▸ CA6 P23280 1/20 0.48
▸ CA5A P35218 1/20 0.48
▸ CA7 P43166 1/20 0.48
▸ MCL1 Q07820 1/20 0.48
▸ CA9 Q16790 1/20 0.48
▸ SOST Q9BQB4 1/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ CA14 Q9ULX7 1/20 0.48
▸ CA5B Q9Y2D0 1/20 0.48
▸ BCHE P06276 1/20 0.34
▸ ACHE P22303 1/20 0.34
▸ NOTUM Q6P988 1/20 0.34
▸ CDK7 P50613 4/20 0.34
▸ CCNH P51946 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Coumarin SCHEMBL3710909 0.91 CA12 (0.57) CA12CA1CA2LMNACA3
Coumarin SCHEMBL28816458 0.83 CA12 (0.69) CA12CA1CA2LMNACA3
Piperidine SCHEMBL5332373 0.82 OXTR (0.43) LMNANOTUMGHSRCLK1DYRK1A
Coumarin SCHEMBL4013018 0.79 — —
Aziridine SCHEMBL31305856 0.77 OXTR (0.47) LMNANOTUMGHSRCLK1DYRK1A
Coumarin SCHEMBL27928273 0.76 CA12 (0.77) CA12CA1CA2LMNACA3
Chromone SCHEMBL3632887 0.75 MAOA (0.49) ACHENOTUMGHSRCLK1DYRK1A
Piperidine SCHEMBL11599158 0.74 OXTR (0.44) LMNAMEN1KMT2A
Coumarin SCHEMBL28474090 0.74 CA12 (0.87) CA12CA1CA2LMNACA3
Coumarin SCHEMBL28593449 0.74 CA12 (0.87) CA12CA1CA2LMNACA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2141994-A1 MULTI-RING COMPOUNDS AND USES THEREOF Avalon Pharmaceuticals (US) 2010-01-13 — — EP disclosed
WO-2008133975-A1 MULTI-RING COMPOUNDS AND USES THEREOF AVALON PHARMACEUTICALS (US) 2008-11-06 — — WO disclosed
Send feedback